Latest net tangible assets for ECTE: $-6.3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest net tangible assets for ECTE is $-6.3M as of September 2016. That compares with $-1.9M in the prior-year period — down 237.5% year over year. Investors often review this figure alongside Echo Therapeutics's historical trend and sector peers before judging valuation or financial health.
Over the past year, ECTE's net tangible assets moved from $-1.9M to $-6.3M — a 237.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Echo Therapeutics's operating scale or balance-sheet position.
A net tangible assets figure of $-6.3M for ECTE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting ECTE's net tangible assets ($-6.3M), review year-over-year change from $-1.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.